CS Diagnostics Cash Flow per Share
Operating Cash Flow per Share of CS Diagnostics (CSDX) as of Nov 3, 2026.
Get this data via API
Financial Data API
Cash Flow per Share
0.00USD
YoY
-42.78%
Last updated:
Operating Cash Flow per Share of CS Diagnostics is 2025 0.00 USD. Operating Cash Flow per Share of CS Diagnostics was 2024 0.00 USD. It decreases by -42.78% lower compared to the previous year.
The CS Diagnostics Cash Flow per Share history
3 Years
10 Years
25 Years
Max
Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
| YEAR | Cash Flow per Share | YoY |
|---|---|---|
| 0.00USD | -42.78% | |
| 0.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
CS Diagnostics Stock analysis
What does CS Diagnostics do? FlashZero Corp. develops software to access the internet, focusing on global commerce and idea launching. The company's website enables users to specify and obtain goods and services globally via smartphones and the internet. Users engage with vendors, advertisers, associates, product co-creators, team members, and service providers privately. The firm's products are sold to individuals seeking global resource access and participative support for their concepts.
FlashZero Corp. generates revenue through its software platform, which facilitates private engagement between users and various service providers. The company targets individuals who want to secure resources and support for their ideas, leveraging smartphone and internet connectivity. Its primary customers are users looking to access global commerce and collaborate with vendors and co-creators.
The business model centers on a software platform that connects users with global vendors and service providers. Revenue comes from facilitating these private engagements, with no mention of additional products or services beyond the core platform. The company's focus is on enabling users to obtain goods and services while securing support for their concepts through the platform. CS Diagnostics is one of the most popular companies on Eulerpool.
Frequently Asked Questions about CS Diagnostics stock
On Eulerpool you can find the complete historical development of Operating Cash Flow per Share CS Diagnostics since 2006 – with annual values, charts, and detailed analysis.
Operating cash flow per share measures the operating cash generated per outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — CS Diagnostics
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — CS Diagnostics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth